π€ AI Summary
This study addresses the challenge of accurately characterizing the infectiousness trajectory of SARS-CoV-2βinfected individuals, which cannot be directly measured and must rely on indirect proxies. Leveraging longitudinal, multimodal data from approximately 2,000 infected participants across five prospective cohorts, we propose a novel Bayesian joint model that simultaneously integrates PCR viral load, viral culture results, and symptom dynamics to precisely infer individual and population-level infectious viral shedding. The approach enables real-time prediction of individual infectiousness using routine PCR testing alone and supports stratified assessment by variant, vaccination status, and prior infection history. We quantify population-level transmission probabilities at various time points post-diagnosis, residual risk after isolation discontinuation, and provide personalized, dynamically updated infectiousness forecasts as new test data become available.
π Abstract
During an infectious disease outbreak, providing accurate answers to policy questions about transmission requires a detailed model of the natural history of infectiousness. Unfortunately, direct measures of infectiousness are generally unavailable. Instead, we often rely on indirect proxies, such as viral load measured by PCR or antigen tests, viral culture to detect replication-competent virus, or symptom onset, each of which reflects different aspects of viral dynamics or host response. However, these proxies vary in terms of the ease of collection, scalability, and their relationship to viral shedding and therefore underlying infectiousness. Here, we use data from five prospective, densely sampled cohorts with longitudinal data on multiple proxies of viral shedding for approximately 2,000 infections to develop a Bayesian joint model for the within-host viral kinetics of SARS-CoV-2 infection. Modeling the joint distribution allows us to infer the trajectory of infectious virus shedding -- the most direct correlate of infectiousness -- for individuals who contribute only PCR data, and to compute derived quantities that are inaccessible from any single proxy alone. These include the population-level probability and expected duration of ongoing infectiousness as a function of time since diagnosis, stratified by variant, vaccination status, and infection history; the residual risk of releasing an individual from isolation; and personalized, real-time estimates of infectiousness that are sequentially updated as new test results become available.